Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors

NCT07602842 is registered in ClinicalTrials.gov with InduPro, Inc. as lead sponsor.

NCT NCT07602842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors
Lead sponsor
InduPro, Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 8, 2026
Completion date
December 31, 2028
Enrollment
132 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, cutaneous squamous cell carcinoma, head and neck squamous cell carcinoma, metastatic solid tumor, non squamous non small cell lung cancer, squamous cell carcinoma, squamous cell carcinoma of the anus, squamous cell carcinoma of the cervix, squamous cell carcinoma of the esophagus